| Name | Title | Contact Details |
|---|
Diamedix Corp. is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EY LABS is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
KoKo, LLC is a global respiratory information systems software developer and medical device manufacturing company. The exclusive provider of Iris™, the world`s first Integrated Respiratory Information System; and KoKo® pulmonary function testing, diagnostic spirometry, and respiratory home monitoring devices. Our expert, scalable software solutions and sophisticated data collection products empower healthcare providers to advance respiratory diagnostic processes and improve patient outcomes while meeting the demanding clinical and business objectives of thought leaders in respiratory care.
CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. At CHF Solutions, we are committed to the relentless pursuit of identifying and developing innovative solutions to address unmet clinical needs with the goal of benefiting patients, medical practitioners, and the broader healthcare community.
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe